Managing IP is part of the Delinian Group, Delinian Limited, 8 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings

How to overcome antimicrobial resistance IP challenges

Charlotte Kilpatrick
June 24, 2021
Share
amr-photo-min.jpeg

Biotech companies explain what they need besides patents to help them invest in antimicrobial resistance research

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login

Tags

IP StrategyNewsInternationalPatents
kilpatrick-charlotte-300px.png
Charlotte Kilpatrick
Reporter Managing IP
Contact
Charlotte reports on patent-related issues. She often covers the European market, focusing on developments including FRAND, licensing and trade secrets. She is particularly interested in how new technologies affect IP challenges in the pharmaceutical industry.
more from across site and ros bottom lb

More from across our site

SupremeCourtWinCOVER.jpg
Weekly take: SCOTUS should limit Lanham Act reach
The Supreme Court, which is hearing two IP cases this week, should limit the power of US courts to rule on foreign sales
Rani Mehta, March 20, 2023
US capitol map washington dc
Safety first: senators introduce bill to protect standards copyright
Safety standards wouldn’t lose copyright protection when named in law, so long as they were accessible for free online
Rani Mehta, March 17, 2023
TEchAmgenCOVER.jpg
Tech IP counsel wary of overreaching Amgen v Sanofi ruling
In-house tech sources say Amgen v Sanofi has the potential to stifle their prosecution and litigation strategies if SCOTUS’s decision is too broad
Rani Mehta, March 17, 2023
rolls.jpg
This week on MIP: InterDigital v Lenovo ruling, India’s legal market opens
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
Max Walters, March 17, 2023
Apple2COVER.jpg
Fed Circuit Apple ruling has little Fintiv impact: counsel
The Federal Circuit said tech firms can challenge the way the USPTO implemented Fintiv, but that won’t mean much for practitioners, say counsel
Rani Mehta, March 16, 2023
Rolls 2k-comp.jpg
Lenovo to pay InterDigital $138.7m for FRAND royalty
The England and Wales High Court handed down one of the most hotly anticipated FRAND rulings for some time
Max Walters, March 16, 2023
Portfolio funding.jpeg
Patent funders remain wary of picking bad apples
Funders discuss different IP portfolio funding options and how they decide whether to offer preferential terms and pricing
Sukanya Sarkar, March 16, 2023
Elephant take-comp.jpg
Weekly take: Milan court is UPC elephant in the room
The issue of the Unified Patent Court’s third central division needs resolving before IP owners can fully embrace Europe’s new era
Max Walters, March 16, 2023
India on map.jpeg
India opens legal market to foreign law firms
Foreign firms and lawyers, including IP practitioners, can now practise in India after years of talk and no action
Sukanya Sarkar, March 15, 2023
Delhi HC.jpeg
Talk of IP divisions excites counsel but Delhi remains top
Most Indian counsel won’t immediately look beyond the Delhi High Court for IP cases, but new forums could potentially change their minds
Sukanya Sarkar, March 15, 2023